Literature DB >> 30625493

Anti-Inflammatory Effect of Lycopene on Experimental Spinal Cord Ischemia Injury via Cyclooxygenase-2 Suppression.

Ye Hua1, Nanfei Xu1, Tao Ma1, Yumin Liu1, Hong Xu1, Yunnan Lu2.   

Abstract

OBJECTIVE: Spinal cord ischemia/reperfusion injury (SCII) is a devastating complication following thoracoabdominal aortic surgeries, often leading to severe neurological deficits. We sought to examine the effects of lycopene, a naturally existing carotenoid with anti-inflammatory properties, in the treatment against SCII.
METHODS: Rats were assigned into four treatment groups: Sham (sham operation), SCII (SCII-induction), LY25, and LY50 (lycopene treatment at 25 or 50 mg/kg following SCII induction, respectively).
RESULTS: Lycopene treatment improved the recovery of neurological functions following SCII and suppressed the neuronal cell death and neuroinflammation at 14 days after SCII. Furthermore, Western blot assay revealed that lycopene treatment attenuated the SCII-induced increase in the protein levels of cyclooxygenase-2 (COX-2), nuclear factor-κB, and activate protein-1, as well as the reduction of heme oxygenase-1.
CONCLUSION: Lycopene exerted neuroprotective functions in SCII and inhibited SCII-elicited neuroinflammation via COX-2 suppression.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Cyclooxygenase-2; Heme oxygenase-1; Inflammation; Lycopene; Spinal cord ischemia/reperfusion injury

Year:  2019        PMID: 30625493     DOI: 10.1159/000495466

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  9 in total

1.  Tat-p27 Ameliorates Neuronal Damage Reducing α-Synuclein and Inflammatory Responses in Motor Neurons After Spinal Cord Ischemia.

Authors:  Woosuk Kim; Hyun Jung Kwon; Hyo Young Jung; Kyu Ri Hahn; Seung Myung Moon; Yeo Sung Yoon; In Koo Hwang; Soo Young Choi; Dae Won Kim
Journal:  Neurochem Res       Date:  2021-08-17       Impact factor: 3.996

Review 2.  Antioxidant Therapies for Neuroprotection-A Review.

Authors:  Raluca Ioana Teleanu; Cristina Chircov; Alexandru Mihai Grumezescu; Adrian Volceanov; Daniel Mihai Teleanu
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 3.  Hormetic Effects of Bioactive Compounds from Foods, Beverages, and Food Dressing: The Potential Role in Spinal Cord Injury.

Authors:  Anna Lucia Fedullo; Mario Ciccotti; Paolo Giannotta; Federica Alviti; Marco Bernardi; Anna Raguzzini; Elisabetta Toti; Tommaso Sciarra; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2021-02-27       Impact factor: 6.543

Review 4.  Carotenoids from Marine Sources as a New Approach in Neuroplasticity Enhancement.

Authors:  Sylwia Pietrasik; Natalia Cichon; Michal Bijak; Leslaw Gorniak; Joanna Saluk-Bijak
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

5.  Long non-coding RNA H19 contributes to spinal cord ischemia/reperfusion injury through increasing neuronal pyroptosis by miR-181a-5p/HMGB1 axis.

Authors:  Lili Guo; Dan Wang; Hildrich Yasmal Alexander; Xiaoyan Ren; Hong Ma
Journal:  Aging (Albany NY)       Date:  2022-07-05       Impact factor: 5.955

Review 6.  Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19).

Authors:  Banlambhabok Khongthaw; Kanika Dulta; Pankaj Kumar Chauhan; Vinod Kumar; Joshua O Ighalo
Journal:  Inflammopharmacology       Date:  2022-09-01       Impact factor: 5.093

Review 7.  Effects of Lycopene Attenuating Injuries in Ischemia and Reperfusion.

Authors:  Sijia Wu; Xiajun Guo; Jia Shang; Yuanyuan Li; Wanglin Dong; Qianwen Peng; Zhenxing Xie; Chaoran Chen
Journal:  Oxid Med Cell Longev       Date:  2022-10-07       Impact factor: 7.310

Review 8.  Marine Biocompounds for Neuroprotection-A Review.

Authors:  Adrian Florian Bălașa; Cristina Chircov; Alexandru Mihai Grumezescu
Journal:  Mar Drugs       Date:  2020-05-31       Impact factor: 5.118

Review 9.  Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection.

Authors:  Sajad Fakhri; Akram Yarmohammadi; Mostafa Yarmohammadi; Mohammad Hosein Farzaei; Javier Echeverria
Journal:  Mar Drugs       Date:  2021-03-19       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.